Stefan Knapp
Goethe University Frankfurt(DE)Goethe-Institute United Kingdom(GB)German Cancer Research Center(DE)University of Toronto(CA)Heidelberg University(DE)Frankfurt Institute for Advanced Studies(DE)Structural Genomics Consortium(CA)University of California System(US)University of California San Diego(US)German Cancer Society(DE)Oklahoma State University Oklahoma City(US)Research Network (United States)(US)Frankfurt Cancer Institute(DE)OU Health Stephenson Cancer CenterDeutschen Konsortium für Translationale Krebsforschung(DE)RWTH Aachen University(DE)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Ubiquitin and proteasome pathways, Multiple Myeloma Research and Treatments, Protein Kinase Regulation and GTPase Signaling, Cancer Mechanisms and Therapy
Most-Cited Works
- → Selective inhibition of BET bromodomains(2010)4,233 cited
- → Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family(2012)1,724 cited
- → Targeting bromodomains: epigenetic readers of lysine acetylation(2014)1,228 cited
- → The promise and peril of chemical probes(2015)841 cited
- → Trends in kinase drug discovery: targets, indications and inhibitor design(2021)738 cited
- → Copper is required for oncogenic BRAF signalling and tumorigenesis(2014)585 cited
- → Critical Residues for Structure and Catalysis in Short-chain Dehydrogenases/Reductases